Purpose: Quantitative evaluation of dynamic contrast enhanced MRI (DCE-MRI) allows for estimating perfusion, vessel permeability, and tissue volume fractions by fitting signal intensity curves to pharmacokinetic models. These compart mental models assume rapid equilibration of contrast agent within each voxel. However, there is increasing evidence that this assumption is violated for small molecular weight gadolinium chelates. To evaluate the error introduced by this invalid assumption, we simulated DCE-MRI experiments with volume fractions computed from entire histological tumor cross-sections obtained from murine studies. 
INTRODUCTION
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is carried out by acquiring sequential T 1 -weighted images before, during, and after the intravenous injection of a gadolinium-based contrast agent. As the contrast agent is delivered into a tissue of interest, it decreases the native T 1 relaxation time, thereby increasing the measured signal intensity. As the contrast agent leaves the tissue, relaxation time returns to baseline, resulting in a return to baseline in signal intensity. Therefore, each voxel within the image series yields a signal intensity time-course that can then be analyzed with a pharmacokinetic model to return estimates of parameters of physiological interest related to (for example) vessel perfusion and permeability and tissue volume fractions (1) . These parameters, which can be obtained on a region-of-interest or individual voxel scale, find application in both diagnostic (2) (3) (4) (5) and prognostic (6) (7) (8) (9) settings in various cancers. Because of leaky and fragile tumor-associated vasculature, DCE-MRI has a well-established presence in the quantitative imaging of cancer (10) (11) (12) (13) .
The standard approach to analyzing DCE-MRI data is the 2-compartment Tofts-Kety model, which describes the exchange of contrast agent between the vascular and extravascular-extracellular spaces (14) . The use of the parameters returned from a model is fundamentally limited by the ability of the model to sufficiently and realistically capture the in vivo behavior. A fundamental assumption of most DCE-MRI models is that contrast agent is actively delivered throughout each voxel via blood vessels and not through passive intervoxel diffusion. There is an increasing body of evidence indicating that this assumption can lead to significant estimation errors of the desired pharmacokinetic parameters, and extended models accounting for both active delivery and intervoxel diffusion have been proposed (3, (15) (16) (17) (18) . These methods show promise in improving the accuracy of many dynamic contrast-enhanced imaging modalities, particularly those using fast-diffusing contrast agents.
A second limitation of the standard model is the assumption of instantaneous and uniform filling of the extravascular extracellular space (EES). In its original implementation, the Kety model was used to measure the concentration of solvated gasses in the 2 compartments of interest, and as such, assumes a high molecular diffusivity of the solvate (19) . However, in DCE-MRI, the contrast agent is many times larger than a gaseous molecule and therefore has a lower characteristic diffusivity, D. In fact, the range of D for gadolinium chelates has been measured to be 1-4 Â 10 À4 mm 2 s À1 (20, 21) , which is multiple orders of magnitude less than that of the typical gases dissolved in tissue (17-1,010 mm 2 s À1 ) (22, 23) . Assuming unhindered 3D diffusion in water, the mean displacement of gaseous particles is on the order of 10 mm in 1 s, compared to $0.04 mm for Gd-DTPA. For comparison, the apparent diffusion coefficient of water in cancerous tissue is $0.01-3 Â 10 À3 mm 2 s À1 (6), equivalent to a mean displacement of 0.13 mm in 1 s. In tissues like the heart, the above assumption may be valid, because of a combination of high flow and high capillary density (24) . In cancers with limited perfusion, the assumption that the domain is uniformly filled may be incorrect, thereby introducing a systematic parameterization error. To account for this possibility, Larson et al. (25) proposed models that incorporate the possibility of non-uniform contrast agent distribution, making use of virtual compartments. However, these models are complex and require high-temporal resolution and high signal-to-noise data to accurately fit parameters (26) . Further, validation of models using virtual compartments is challenging. Owing to its relative simplicity, the extended Tofts-Kety model has become standard for quantitative DCE-MRI analysis (27) . Barnes et al. (28) investigated the effect of intravoxel diffusion on the accuracy of the standard model in silico, using simulated domains generated by means of a pseudorandom algorithm for the placement of cells and vessels. It was determined that intravoxel diffusion, within the range of standard gadolinium chelates, introduces significant parameterization error into the analysis of typical DCE-MRI data. They also demonstrated that this parameterization error was eliminated as the contrast agent diffusivity was increased into the gaseous range (28) .
The present study aims to rigorously investigate the effects of intravoxel diffusion of contrast agent, within realistic tissue domains derived from in vivo tumors, on the accuracy of the pharmacokinetic parameters derived from the extended Tofts-Kety model. We hypothesize that parameterization error because of diffusivity will increase as the coefficient of diffusion of the contrast agent decreases. We predict that this occurs because of slow diffusion away from vasculature, resulting in nonuniform filling of the domain. This is in contrast to the assumption of uniform filling of the extra-cellular compartment. In particular, we predict that there will be significant parameterization errors seen in DCE-MRI analysis when using common gadolinium-based contrast agents. These hypotheses will be tested by developing a finite element method (FEM) model of segmented histological slices, obtained from BT474 tumors grown in mice. Figure 1 provides a visual guide through each component of the experiments and data analysis.
METHODS

Histological Analysis
Whereas details are presented in Sorace et al. (29) , the salient features are as presented here. Representative histologically stained images are demonstrated by Figure 1a and the resulting segmentation is shown in Figure 1b . All procedures were approved by the Institutional Animal Care and Use Committee. BT474 (invasive ductal carcinoma) mammary gland cells (10 7 ) were grafted into the hind-flank of adult female fox nu/nu mice (Charles River Laboratories, Wilmington, MA), and tumors were allowed to grow for 4-6 weeks, until the size of the tumor exceeded 200 mm 3 . Animals were humanely sacrificed and tumors were immediately excised and fixed in 10% formalin. Tumors were then stored in 70% ethanol for further processing. Serial slices of the tumor (5-mm thickness) were taken at the center cross-section of the tumor. Hematoxylin and eosin (H&E) (for cell identification) and anti-CD31 (ab28364, Abcam Cambridge, MA) (for endothelial cell and vascularity identification) stains were performed on consecutive histological slices. Slides were digitally scanned at 20 Â resolution (0.5-mm lateral resolution) with bright-field microscopy using a Leica SCN400 Slide Scanner (Leica Microsystems, Ariol, Buffalo Grove, IL) (29) . Digitized CD31 and H&E stains from corresponding mice were then registered by intensitybased rigid transformation (MATLAB Image Processing Toolbox, Natick, MA). H&E images were then segmented into cellular and extracellular regions using color thresholding in hue-saturation-value space. Nuclei were first segmented by thresholding the dark blue stain in H&E, whereas the cytoplasm was segmented from the background by thresholding purple-stained H&E regions. To create an initial mask of cellular space, which was later refined, the masks for nuclei and cytoplasm were combined. The distance transform was carried out on the inverse of the cellularity mask (equivalent to a mask of extracellular space), and the resulting image was watershed-transformed to obtain the edges between cytoplasm and extracellular space. Likewise, the distance transform was carried out on the mask of nuclei, and watershed-transformed to identify the boundary between nuclei and cytoplasm. Finally, each segmented nuclei was morphologically dilated until reaching the boundary between cytoplasm and extracellular space, filling in any small holes in the initial mask of cellularity.
CD31 stains were segmented into vascular and nonvascular space using color thresholding to identify epithelial tissue, and a closing operation (dilation followed by erosion) to fill in open space within blood vessels. Redcolored regions were selected using the hue-saturationvalue color space and then converted into a rough mask of vascularity. This rough mask was then refined by morphological closing, closing the lumen of the blood vessels in the vascular mask, and removing small holes within vascular regions. Objects smaller than 2 mm in diameter were excluded from the vascular mask to accurately represent the segmentation at the lower finite element resolution.
Registered masks of cellularity and vascularity were then down-sampled from 0.5 mm to 2 mm lateral resolution to achieve a reasonable solve time for the FEM (see below). Finally, the mask of extracellular space was modified such each blood vessel has a region of extracellular space 2-mm thick surrounding it. This was done to ensure each vessel could distribute contrast agent to the extravascular extracellular space in all directions, and was not hindered by cellularity directly adjacent to the vasculature. All morphological operations were performed on histological images using a 3 Â 3 pixel sliding window. An example of the resulting segmentation is presented in Figure 1b . All image processing was performed using the MATLAB Image Processing Toolbox (2016a, Natick, MA). Figure 1c visually where C t ðtÞ and C p ðtÞ are the concentration of contrast agent within the tissue and blood plasma compartments at time t, respectively. K trans is the volume transfer rate of the contrast agent from the plasma to the extravascular compartment, and v e is the extravascular extracellular volume fraction (30, 31) . Solving Eq. [1] and including a correction factor for a non-negligible plasma volume fraction, v p (4,31), yields the extended, 2-compartment Tofts-Kety model:
Forward Model
If C p ðtÞ can be measured (or estimated), Eq. [2] can be fit to measured DCE-MRI data to estimate K trans , v e , and v p on a voxelwise basis.
To determine the accuracy of Eq. [2] in tissue, we extend the FEM methodology developed in Barnes et al. (28) . The diffusion equation in 2 dimensions, dcðx; y; tÞ dt ¼ r Á DrCðx; y; tÞ; [3] is used to disperse contrast agent throughout the extravascular extracellular space, where C(x, y, t) is the 2D spatial and temporal distribution of contrast agent within the domain. D is the coefficient of diffusion, or diffusivity (in units of mm 2 s À1 ) of the contrast agent, and is assigned values within the experimentally measured range (1 Â 10
) (20, 21) . The vessel boundary conditions are set such that the flux of contrast agent is determined by an assigned K trans . Further details on the FEM implementation and domain may be found in the FEM Theory section of Supporting Information (a).
To implement boundary conditions between the plasma and extravascular extracellular spaces, we write rC Án ¼ P C p ðtÞ À CðtÞ ; [4] where P is the permeability, defined as (K trans V)/S, with S as the total surface area of the vasculature within the voxel,n is the unit normal vector to the boundary, and V as the volume of tissue within the voxel. C p ðtÞ, is assigned as a constant at each time step, according to a population arterial input function (32, 33) . Because our simulation is in 2D, S is measured as vessel perimeter (mm), and V is measured in units of area (mm 2 ). For simplicity, P (mm Â min À1 ) is assigned as a constant value for all vessel boundaries within the entire tumor domain, such that the voxel containing the maximum S will have a K trans value of 0.5 min À1 , and voxels with no vasculature (i.e., S ¼ 0) have a K trans of 0 min À1 . This is equivalent to scaling K trans from 0 to 0.5 min À1 as S scales from 0 to S max . Further details on FEM mesh development and model implementation can be found in the FEM Mesh section of Supporting Information (b).
These methods constitute the forward model that is used to simulate the spatio-temporal evolution of contrast agent within the histological FEM domain (Fig. 1c) . By changing the model parameters (K trans , v e , v p , D, tissue geometry), the model output (i.e., C(x,y,t)) is determined. The forward model output is then analyzed using the methodology outlined below in the Simulations section to systematically and quantitatively assess the error in the extended Tofts-Kety model on a voxelwise basis, when the assumption of instantaneous and uniform filling of the contrast agent in the extravascular extracellular space is not satisfied. This model was designed such that all the extended Tofts-Kety parameters could be directly measured or assigned. It is not intended to be an exact representation of tumor biology and contrast agent delivery, but an investigational tool that allows fine parametric control in a large variety of biologically relevant geometries under best-case imaging conditions.
Simulations
For implementing the forward model, a range of diffusivities, D, for the common, clinically approved gadolinium-based contrast agents were chosen as 1.0, 2.0, 2.6, and 4.0 Â 10 À4 mm 2 s À1 (20); in particular, 2.6 Â 10 À4 mm 2 s À1 was chosen to simulate Gd-DTPA (Magnevist, Bayer, Berlin, Germany) (21). Each tumor (N ¼ 4) was excised, stained, digitized, segmented, meshed, and evaluated using the forward model with the prescribed values of D. Resulting contrast agent distributions are used to calculate R k 1;voxel for each voxel at each time point k. R k 1;voxel , along with the flip angle a, baseline signal intensity S 0 , and TR, are used to calculate the signal intensity, SI k voxel , in each voxel:
where we have assumed the echo time, TE << T 
Statistical Analysis
After computing the signal intensity for each simulated voxel, the time-course for each voxel is fit to Eq. [2] , using least-squares error minimization in MATLAB (MathWorks, Natick, MA) to provide estimates of K trans , v e , and v p (akin to what would be calculated on a voxelwise basis in a standard, in vivo DCE-MRI study). Estimates of v e and v p are bounded between 0 and 1, and K trans is bounded between 0 and 5 min À1 . This process is represented by the curve-fitting shown in Figure 1c , and the estimated parameters shown in Figure 1f . Finally, these parameters are then compared to the histological (v e , v p ) and assigned (K trans ) parameters, and a percent error is calculated for each simulated voxel ( is the same parameter either measured histologically or assigned in the forward model. %Error voxel values are then used to determine the accuracy of the standard model. These results are reported as mean 6 the 95% confidence interval, at each simulated D ( Table 1 ). Note that voxels with a histological v p ¼ 0 will result in an undefined %Error in v p and K trans , because of a zero denominator, and are omitted from the summary of results in Table 1 . It is important to note that, in all figures, the error in v e has been corrected to reflect the fraction of EES that is accessible to contrast agent and connected to a vascular source. Any EES that is not accessible to the contrast agent is not included in the calculation of the error in v e , except where it is explicitly reported in Table 1 .
Domain Size Analysis
To determine the effect of domain size on the accuracy of the standard model, 3 different domains were considered. These domains consisted of a single 10-mm diameter vessel in empty EES, a single 10-mm diameter vessel surrounded by uniformly spaced (6 mm in all directions) 10-mm diameter cells, and a single vessel surrounded by cells measured using the methods described above in Histological Analysis. In each of these domains, we set zero-flux 
RESULTS
Using a poorly perfused tumor domain (Figure 2a ,
values of D were used to determine the effects of diffusion. The resulting signal intensity time-courses for these simulated scans are depicted in Figure 2b . As D is increased from 1.0 to 4.0 Â 10 À4 mm 2 s À1 , the total amount of contrast agent within the EES increases, corresponding to an increase in total signal enhancement. The results of the FEM simulation for this domain are shown in Figure 2c and Supporting Figure S1 . Initially, at t ¼ 1 min, the distribution of contrast agent within the voxel is extremely uneven. Figure 3a , with increasing total signal enhancement correlating with increasing D (Fig. 3b) . The wellperfused voxel equilibrates much sooner, and with a lower D than the poorly perfused voxel (Fig. 3c and Supporting Fig. S2 ). Parameterization error of K trans improves from À30.3% to 11.7%, error in v e improves from À5.7% to 3.1%, and error in v p improves from 49.9% to 4.3%. Absolute error in v e is notably lower for all values of D in the well perfused voxel (Fig. 3c) , when compared to the necrotic voxel ( Fig. 2c and Supporting Fig. S1 ). Errors in K trans are similar between the 2 sampled voxels, whereas the error in v p is more sensitive to changes in D for the well-perfused voxel. The necrotic domain demonstrates a characteristic slow wash-in and lack of notable wash-out (Fig. 2b) , whereas the well-perfused domain demonstrates both wash-in and wash-out (Fig. 3b) (27) . Figure 4 depicts the means and 95% confidence intervals of the parameterization errors for a single mouse tumor (histology and segmentation of tumor shown in Figures 5d-5f ), using the full range of values of D within the physiological range. Mean error in all parameters approaches zero with increasing D. K trans is most often underestimated, with its mean value below zero at all diffusivities simulated in this study. The confidence interval for K trans error begins to contain positive values at D ¼ 2 Â 10 À4 mm 2 s À1 (Fig. 4a) . Likewise, mean error in v e is negative for all simulated diffusivities, but Eq. (Fig. 4b) . Error in v p is by far the most widely varied, although the estimation of v p improves steadily as D increases (Fig. 4c) . A map of parameterization error in all parameters for D ¼ 2.6 Â 10 À4 mm 2 s À1 is shown in Figures 5a-5c . Areas of high necrosis near the center of Figure S1 .
the tumor demonstrate high error in K trans . This simulation predicts that DCE-MRI, using the imaging parameters in the Methods section, will contain inherent parameterization error of K trans between À32.0% and 8.8%, v e error between À10.0% and 2.4%, and v p between 95.6% and 149.9%.Voxels with a histological v p ¼ 0 are marked with an "X", and are not included in the 95% confidence intervals displayed in Figure 4 , as division by zero is undefined (see Eq. [12] ). Undefined parameterization error most frequently occurs for voxels on the edge of the tumor domain, where the voxel is not completely occupied by tissue, or in regions of necrosis. Supporting Figures S4, S5 , and S6 provide 95% confidence intervals for each individual mouse.
The 95% confidence intervals of the errors demonstrated in Figures 4 and 5 , as well as those found in the remaining subjects, can be seen in Table 1 . This table summarizes our complete results for each specimen (N ¼ 4), at each of the 4 assigned values of D. In aggregate, the mean error of each parameter improves with increasing D. For D ¼ 2.6 Â 10 À4 mm 2 s À1 , the K trans is most often underestimated, whereas the number of voxels overestimated increases with D. The same trend is true of v e . The parameter v p is nearly always overestimated, with error reduced with increasing diffusivity. Note that Table 1 also reports v e error uncorrected for regions without contrast agent accessibility. On average, there is a difference of 20% between values corrected for contrast agent accessibility and raw values without this correction. This difference in error is discussed in detail in the Discussion section. Figure 6c depicts the process using a domain generated from actual histology; the same trend of accumulating error with increasing window size is apparent with all parameters. Because of the pseudo-random distribution of cells, the spikes in error are more present than in the domain with evenly distributed cellularity (Figure 6b) . In general, all parameters are most accurately estimated with a contrast agent of higher diffusivity, and the Eq. [2] estimation of each parameter worsens as the domain increases in size, thereby increasing the distance the contrast agent must travel to fill the domain. This process was performed on a number of other tissue domains and blood vessels, and the same general trend of increasing error with increasing window size was found to hold (results not shown). It should be noted that when v p is reduced below 0.01 (shown with a dashed vertical line in Supporting Figure  S3 ), the extended Tofts-Kety model no longer holds (1, 14) , introducing a high parameterization error in v p .
DISCUSSION
The results above are intended to demonstrate the error because of diffusion in the extended Tofts-Kety model, Figure S2 .
Intravoxel Contrast Agent Diffusion in DCE-MRI
for values of K trans , v e , and v p within tumor domains derived from entire histology slices. These methods enable us to examine situations that arise in biological tissues that might not occur in contrived or overly simplistic models of cell density. Of particular note is the presence of regions within the tumors that, because of the distribution of cells, do not allow for any contrast agent to reach them. Such regions were evident in all 4 tumors studied, suggesting that there could be pockets of tissue in vivo that will not contribute to contrast agentmediated signal enhancement. In our calculation of error, regions of extravascular extracellular space with no possible enhancement were counted in the v eis fraction, and only regions accessible to contrast agent were counted in v e . When non-accessible regions are accounted for, the extended Tofts-Kety model is 20% more accurate in all cases. Volume fractions with isolated regions of extravascular extracellular space can never be quantified using a model of perfusion, and may be better measured via diffusion-weighted MRI (34) . However, this effect may be mitigated in real tissue, given that there will be more physical pathways for the contrast agent to diffuse through in 3 dimensions.
This work focuses on a range of diffusivities D that represents those common for gadolinium based contrast agents. Barnes et al. (28) demonstrated that as D increases into the gaseous range, the domain equilibrates within the time-resolution of a typical DCE-MRI experiment and approaches instantaneous equilibration of contrast agent within the extravascular extracellular space. In particular, with high diffusivity, overestimation of K trans indicates that more contrast agent is present in the voxel than would be indicated by perfusion and permeability alone. Likewise, overestimation of v e indicates that the washout of contrast agent from the voxel is slower than expected, and the voxel is leaking into neighboring voxels (27 Figure 2c clearly demonstrates an unequal distribution of contrast agent within the imaging voxel, and a clear relationship between the total concentration, signal intensity, and contrast agent diffusion. With low D, the rate at which the voxel can fill with contrast agent is limited by the bottleneck of high-concentration at the vessel boundary. The extended Tofts-Kety model dictates that the rate of exchange between the plasma and extravascular extracellular compartments is governed by the concentration gradient between those 2 compartments (Eq. [4] ). Therefore, if contrast agent is unable to quickly diffuse away from the vessel to fill empty portions of the extravascular extracellular space, the amount of contrast agent entering the domain will be limited because of a small gradient between compartments. Figure 5 demonstrates the same phenomenon in terms of distance instead of time. Faster-diffusing contrast agents are able to equilibrate a larger region of the extravascular extracellular space in a shorter time period and therefore will more accurately represent the entire voxel on the time scale of a DCE-MRI experiment. Contrast agents that diffuse more slowly will not be able to evenly fill a large region of extravascular extracellular space and therefore decreases the accuracy of the model.
An example of the error commonly encountered when performing a DCE-MRI experiment, using a temporal resolution of 1.6 s and Gd-DTPA, is depicted in Figure 4 . The large error in K trans is particularly of note because of its common application in diagnosing (2-5) and evaluating response in cancer (6) (7) (8) 29) . Therefore, an accurate estimate of perfusion is necessary to provide accurate predictions of tumor growth and response to therapeutics. By correcting for the error introduced by diffusion, we hypothesize that accurately estimated parameters will have even more predictive power for diagnosis and prognosis. This will require modification of the extended Tofts-Kety model to account for both inter-and intravoxel diffusion.
Previous efforts have investigated methods to improve the accuracy of the extended Tofts-Kety model by treating the tumor as a continuum, while accounting for intervoxel diffusion between boundaries (3,15-18). These models are applicable for using fast-diffusing contrast agents or for correcting for necrotic regions of the tumor where the only source of signal enhancement is from the diffusion of contrast agent from neighboring voxels. They do not, however, account for the underestimation of K trans and v e resulting from intravoxel diffusion as demonstrated in the routine preclinical DCE-MRI procedures using common gadolinium chelates described in this manuscript.
Our study of intravoxel diffusion was limited because of stability requirements (Eq. [12] , Supporting Information); evaluating the forward model for an entire tumor domain at D > 4 Â 10 À4 mm 2 s À1 was prohibitively long. By taking advantage of mesh partitioning and parallelization, we could potentially extend our model to analyze contrast agents with diffusivities in the gaseous range (0.17-10.1 cm 2 s À1 ) (6,7), although CA in this range of diffusivity would likely not be delivered through injection. Decreasing the simulation time would also allow for simulations of the Tofts-Kety model within the flowlimited regime, as increased contrast agent velocity would require finer time-steps. For the same reasons, the spatial resolution of our model is limited to 2 mm in the imaging plane, and it is assumed that each blood vessel is surrounded by at least 2 mm of extracellular space. This was a necessary assumption to allow contrast agent to enter the domain from all directions from any given vessel. In real tissue, even with cells directly adjacent to the vasculature, we expect gaps that are smaller than 2 mm or paths that are accessible via the third spatial dimension. These small gaps would allow contrast agent to travel more freely within the tumor as compared to the forward model we have presented. However, as gaps become smaller, diffusion becomes restricted, and the rate of contrast agent dispersion is decreased. Our ability to model the domain is limited to structures above 2 mm, potentially limiting the accuracy of our simulations in regions with high cellularity. Our model is also limited in that the concentration within the plasma compartment is constant in space, and varies temporally with the given population arterial input function (32) . This means our analysis is limited to the permeability limited case of the Tofts-Kety model (30) . This analysis does not accurately reflect tissues in the flow-limited regime of the extended Tofts-Kety model. Any significant flow could more effectively deliver contrast agent to the tissue, potentially leading to greater distribution of the agent throughout the extravascular extracellular space, thereby helping to reduce the error demonstrated by the above results. Implementation of a similar analysis for flow-limited perfusion would most likely require the characterization of volumetric flow (we note that others have implemented flow in 2D) (16) . As K trans in many types of cancer is thought to depend on both permeability and flow, the permeability-limited extreme may not represent the majority of tissue physiologies. For this reason, we limit the applicability of this analysis to solid tumors with poor vascularization and perfusion (35, 36) . BT474 tumors were selected for the present study as they provide a range of physiologies from well-perfused to necrotic. Although we anticipate that the general trends observed in this study would also be observed in other tumor types, the degree to which they are achieved would be dependent on their specific vascular features.
Additional limitations of the present study are related to the fact that biological domains are 3D, therefore any 2D simplification will misrepresent reality. In 2D, the contrast agent within the vasculature may immediately leave the voxel, whereas C p (t) may vary along the length of a vessel in 3D. Regions in 2D that are inaccessible to the contrast agent may be accessible in the third dimension. As these issues are complicating factors in 3D, we investigated a 2D model specifically to probe the effects of slow contrast agent diffusion on DCE-MRI parameter accuracy and decouple the analysis from (other) confounding factors. Finally, we offer no immediate solution to eliminate this error from the analysis of DCE-MRI. Potential methods for correcting this model may explicitly include the molecular diffusivity of the contrast agent, as well as including prior knowledge of the spatial distributions of vascular and cellular volume fractions obtained from other imaging techniques.
Future efforts will investigate the effect of the flowlimited case, requiring alternative treatment of the plasma compartment, K trans and inclusion of a perfusion term in the FEM. Investigating the problem in 3D may be explored via high-resolution 3D imaging techniques (e.g., confocal, multiphoton, or light-sheet microscopy) to establish experimentally motivated computational domains (37) . Future work may also include methods of parameterizing the spatial distribution of blood vessels within a voxel, as vessel proximity to a voxel boundary plays a central role in intervoxel exchange of contrast agent. Additionally, future development of a diffusion-corrected inverse model for DCE-MRI is of interest.
CONCLUSION
The purpose of this study was to illustrate the effect of diffusion of contrast agent on parameterization error in the analysis of quantitative DCE-MRI data. By simulating the distribution of contrast agent within an entire tumor domain, we are able to highlight the sources of error that might be seen in a typical DCE-MRI experiment. More specifically, by using histological stains of cellularity and vascularity, highly realistic tumor domains were generated for FEM implementation of the extended Tofts-Kety model at sub-MRI-voxel resolution. From these simulations, we were able to perform simulated DCE-MRI experiments, compare assigned (K trans ) and histologically measured parameters (v e and v p ) with those estimated by curve-fitting to the extended Tofts-Kety model, and produce a spatial map of parameterization error. Our results show that diffusion plays a measurable and significant role in determining the accuracy of the current widely used DCE-MRI model and point toward the need for an improved model that accounts for the diffusion of contrast agent within and between voxels. 
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Additional Supporting Information may be found in the online version of this article. Fig. 2 and Supporting Fig. S1 ), accuracy in K trans and v e is positively correlated with increasing D. Higher v p accuracy in the wellperfused voxel, compared to the poorly perfused voxel, is because of the increased vascularity in the domain (v p 5 0.009). Fig. S3 . Depiction of the parametric error as a function of domain size for parameters v e and v p . Error in K trans can be seen in Figure 6 . (a) Corresponds to the domain shown in Figure 6a , while (b) corresponds to the domain shown in Figure 6b This non-smooth behavior is unavoidable using discretized steps in an irregular domain. The curves are less smooth for real tissue data, shown in (c). , v e 5 0.164, and v p 5 0.024. The FEM model is able to recapitulate experimentally measured curve shapes in both poorly and well-perfused regions. When the region is poorly perfused (e.g., the green ROI), analysis with the extended Tofts model leads to non-physiological parameter estimations. When the region is well-perfused (e.g., the blue ROI), the extended Tofts model returns reasonable parameter values.
